Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BO-112 |
Trade Name | |
Synonyms | BO 112|BO112 |
Drug Descriptions |
BO-112 is a nanoparticle formulation of a synthetic double stranded RNA (poly I:C) complex, which potentially enhances anti-tumor immune response, induces apoptosis, and decreases tumor growth (PMID: 31046839). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177439 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BO-112 | BO-112 | 0 | 1 |
BO-112 + Nivolumab | BO-112 Nivolumab | 0 | 2 |
BO-112 + Pembrolizumab | BO-112 Pembrolizumab | 0 | 3 |